PLoS ONE (Jan 2017)

T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.

  • Curtis McMurtrey,
  • Melanie J Harriff,
  • Gwendolyn M Swarbrick,
  • Amanda Duncan,
  • Meghan Cansler,
  • Megan Null,
  • Wilfried Bardet,
  • Kenneth W Jackson,
  • Deborah A Lewinsohn,
  • William Hildebrand,
  • David M Lewinsohn

DOI
https://doi.org/10.1371/journal.pone.0188288
Journal volume & issue
Vol. 12, no. 11
p. e0188288

Abstract

Read online

HLA-E is a non-conventional MHC Class I molecule that has been recently demonstrated to present pathogen-derived ligands, resulting in the TCR-dependent activation of αβ CD8+ T cells. The goal of this study was to characterize the ligandome displayed by HLA-E following infection with Mycobacterium tuberculosis (Mtb) using an in-depth mass spectrometry approach. Here we identified 28 Mtb ligands derived from 13 different source proteins, including the Esx family of proteins. When tested for activity with CD8+ T cells isolated from sixteen donors, nine of the ligands elicited an IFN-γ response from at least one donor, with fourteen of 16 donors responding to the Rv0634A19-29 peptide. Further evaluation of this immunodominant peptide response confirmed HLA-E restriction and the presence of Rv0634A19-29-reactive CD8+ T cells in the peripheral blood of human donors. The identification of an Mtb HLA-E ligand that is commonly recognized may provide a target for a non-traditional vaccine strategy.